中国人群慢阻肺高危临床与炎症聚类
该研究在东南亚三国六家医院前瞻性纳入1480例稳定期中国慢阻肺患者,分推导与验证队列随访超过2年,用无监督层次聚类识别出五个临床聚类,中心血管簇和既往结核簇死亡率最高且炎症网络复杂,提示应据临床与炎症特征进行风险分层。
要点
- 中国慢阻肺患者可聚为五类,中心血管簇和既往结核簇为高危簇。
- 心血管簇与既往结核簇死亡率最高,且独立于GOLD评估。
- 两高危簇呈现不同细胞因子模式与复杂炎症网络。
核心结论
- 中国慢阻肺患者存在五个临床聚类,其中两个为高危聚类。
- 心血管簇和既往结核簇死亡率最高,伴显著炎症和复杂细胞因子网络。
- 建议对中国慢阻肺患者进行临床与炎症风险分层以改善预后。
研究设计与样本
- 前瞻性招募稳定期中国慢阻肺患者,分推导队列与验证队列,来自新加坡、马来西亚和香港六家医院,共1480例。
- 每例患者随访超过2年,采用无监督层次聚类并验证,确定患者聚类及其预后。
- 在336例子集中进行系统性细胞因子评估,分析炎症模式与网络是否对应 derived clusters。
主要发现
- 识别出五个聚类:既往结核簇、糖尿病簇、低共病低风险簇、低共病高风险簇和心血管簇。
- 心血管簇和既往结核簇死亡率最高,且独立于GOLD评估。
- 心血管簇和既往结核簇呈现多样细胞因子模式和复杂炎症网络。
关键数值与推荐
- 共纳入1480例稳定期中国慢阻肺患者,分推导和验证队列,随访超过2年。
- 细胞因子评估在336例子集中进行。
- 识别出五个聚类:既往结核、糖尿病、低共病低风险、低共病高风险和心血管。
- 心血管簇和既往结核簇死亡率最高,独立于GOLD评估。
临床怎么用
- 临床可依据共病和炎症特征对中国慢阻肺患者进行风险分层。
- 对心血管簇和既往结核簇等高危患者考虑靶向干预以改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COPD is a heterogeneous disease demonstrating inter-individual variation. A high COPD prevalence in Chinese populations is described, but little is known about disease clusters and prognostic outcomes in the Chinese population across Southeast Asia. We aim to determine if clusters of Chinese patients with COPD exist and their association with systemic inflammation and clinical outcomes. RESEARCH QUESTION: We aim to determine if clusters of Chinese patients with COPD exist and their association with clinical outcomes and inflammation. STUDY DESIGN AND METHODS: Chinese patients with stable COPD were prospectively recruited into two cohorts (derivation and validation) from six hospitals across three Southeast Asian countries (Singapore, Malaysia, and Hong Kong; n = 1,480). Each patient was followed more than 2 years. Clinical data (including co-morbidities) were employed in unsupervised hierarchical clustering (followed by validation) to determine the existence of patient clusters and their prognostic outcome. Accompanying systemic cytokine assessments were performed in a subset (n = 336) of patients with COPD to determine if inflammatory patterns and associated networks characterized the derived clusters. RESULTS: Five patient clusters were identified including: (1) ex-TB, (2) diabetic, (3) low comorbidity: low-risk, (4) low comorbidity: high-risk, and (5) cardiovascular. The cardiovascular and ex-TB clusters demonstrate highest mortality (independent of Global Initiative for Chronic Obstructive Lung Disease assessment) and illustrate diverse cytokine patterns with complex inflammatory networks. INTERPRETATION: We describe clusters of Chinese patients with COPD, two of which represent high-risk clusters. The cardiovascular and ex-TB patient clusters exhibit high mortality, significant inflammation, and complex cytokine networks. Clinical and inflammatory risk stratification of Chinese patients with COPD should be considered for targeted intervention to improve disease outcomes.
引用
- Tiew PY, Ko FWS, Narayana JK, et al. "High-Risk" Clinical and Inflammatory Clusters in COPD of Chinese Descent. Chest. 2020. PMID: 32092320. doi:10.1016/j.chest.2020.01.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。